Prof. Raimon Jané Campos is a leading figure in biomedical signal processing at the Universitat Politècnica de Catalunya (UPC) and Universitat de Barcelona (UB). As co-director of UPC's Biomedical Signal and System Group (CREB) and coordinator of the Biomedical Engineering PhD Programme, he bridges engineering and clinical applications. His work focuses on respiratory and sleep disorder diagnostics, with significant contributions to COPD and sleep apnea monitoring through wearable devices and machine learning. PhD in Biomedical Engineering (UPC, 1989) Visiting researcher at Université de Nice-Sophia Antipolis Vice-president of Spanish Society of Biomedical Engineering Research spans respiratory mechanics , sleep-disordered breathing , acoustic biomarkers , bioimpedance , and machine learning in biomedical contexts . His 2025 work on microcalorimetric pathogen classification and 2024 spiking neural networks for apnea detection demonstrate cutting-edge integration of computational methods with physiological monitoring. Articles from 2017-2024 reveal consistent focus on non-invasive diagnostics , cardiorespiratory synchronization , and smartphone-based health solutions . Awarded the Barcelona City Technology Research Award (2005) and serving on the International Advisory Board for Physiological Measurement since 2010, his career combines academic leadership with real-world clinical translation through IBEC's technology transfer initiatives.
Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.
Julia Camps is a postdoctoral research associate at the University of Oxford, Department of Computer Science. Her work bridges Computational Biology and Health Informatics, focusing on cardiac digital twin development for precision medicine applications. She specializes in combining data-driven and mechanistic approaches for in silico clinical trials, particularly through Purkinje network modeling and ECG-based calibration. Education: Informatics Engineer (2014) and Master's in Artificial Intelligence (2015-2017) from Universitat Politècnica de Catalunya PhD in Computer Science (2017-2021) at Oxford, completed within the Computational Cardiovascular Science research group under Prof Blanca Rodriguez Current role: postdoc in Prof Rodriguez's group since 2021, focusing on post-myocardial infarction disease progression Software development: open-source cardiac digital twin tools available on GitHub Her research interests center on creating patient-specific cardiac digital twins using multimodal clinical data. This work enables virtual therapy evaluation and in silico clinical trials through: Integration of statistical inference and machine learning techniques Development of Purkinje network models from clinical ECG data Electrophysiological and repolarization sequence modeling Gait detection algorithms for Parkinson's disease applications Recent publications (2024-2025) demonstrate trends in: GPU-accelerated cardiac electrophysiology simulations (MonoAlg3D) Topology-informed ECG electrode localization Sex-specific electromechanical cardiac modeling Multi-modal characterisation of diabetic cardiac deterioration Pro-arrhythmic risk assessment for stem cell therapies
Omer T Inan is the Regents Entrepreneur Endowed Chair and Assistant Professor at the School of Electrical and Computer Engineering (ECE) at Georgia Institute of Technology. His work bridges biomedical engineering and wearable technology, focusing on non-invasive physiological monitoring for chronic disease management. He holds a Ph.D. in Electrical Engineering from Stanford University (2009) and previously worked at Countryman Associates (2007-2013) as Chief Engineer, developing professional audio systems. Education: B.S., M.S., Ph.D. in Electrical Engineering, Stanford University (2004-2009) His research interests include medical devices for home-based cardiovascular monitoring, musculoskeletal sound analysis, and neuromodulation of stress responses. He has pioneered technologies for heart failure patients, PTSD treatment, and osteoarthritis diagnostics. Recent publications highlight innovations in AI-driven cardiac parameter estimation, motion artifact removal in seismocardiograms, and multimodal stress tracking via wearables. His work spans biomedical signal processing, clinical translation, and portable diagnostic systems. Scientific Awards 2024 IEEE Fellow 2023 IEEE Distinguished Lecturer 2023 American College of Cardiology Fellow 2022 American Institute for Medical and Biological Engineering Fellow 2021 Academy Award for Technical Achievement (The Oscars) 2018 ONR Young Investigator Award 2018 NSF CAREER Award At Georgia Tech, Inan leads the Inan Research Lab, which develops technologies for physiological monitoring and modulation. Projects include musculoskeletal sound analysis for joint health, non-invasive cardiovascular sensing, and neuromodulation to treat PTSD via vagal nerve stimulation.
Mike Climstein serves as a Lecturer in Human Sciences within the Faculty of Health at Southern Cross University (SCU), where he coordinates the Master of Clinical Exercise Physiology program and acts as Deputy Academic Integrity Officer. He concurrently holds an adjunct Associate Professor position in the Physical Activity, Lifestyle, Ageing and Well-being Research Group at the University of Sydney and directs SCU's Aquatic Based Research initiative. His academic credentials include a PhD in Exercise Science & Human Performance from Oregon State University (1990), an MSc in Exercise Science from Utah State University (1986), and a BSc in Biology from Utah State University (1982). Climstein's research spans clinical exercise physiology with emphases on master athletes' health, chronic disease rehabilitation, sports injury surveillance (particularly surfing), cardiac rehabilitation, smart textile monitoring, and osteoporosis. His work integrates technology-driven health solutions with population-specific exercise interventions, notably for aging populations and athletes. Analysis of his recent publications reveals three dominant trends: 1) AI applications in dermatological diagnostics (e.g., melanoma detection systems), 2) physiological adaptations in aging populations through martial arts and aquatic exercise, and 3) epidemiological studies of chronic conditions in master athletes and occupational groups. These reflect his dual focus on technological innovation and practical health interventions. His scientific recognition includes: Fellowship by Sports Medicine Australia (FASMF) Fellowship by American College of Sports Medicine (FACSM) Fellowship by Exercise and Sports Science Australia (FAAESS) Climstein actively supervises 4 PhD and 2 Master's students while co-supervising 6 Doctor of Physiotherapy candidates. His research program is supported by 38 grants totaling over $7.8 million AUD, including studies on aquatic rehabilitation and smart textile monitoring. As Director of Aquatic Based Research, he leads interdisciplinary teams investigating water-based exercise interventions for chronic disease management, with ongoing projects in cardiac rehabilitation and osteoporosis prevention.
Nicolas Gaspard is an Assistant Professor at Yale School of Medicine, specializing in neurology and critical care neurophysiology. His research focuses on epilepsy, particularly status epilepticus, NORSE/FIRES syndromes, and EEG monitoring in acute neurological conditions. He leads studies on therapeutic interventions (e.g., electrical stimulation, neuroprotective agents) and outcome prediction in cardiac arrest and epilepsy patients. Collaborations include teams at Yale and international institutions, with a focus on translational research and clinical practice improvements. Education: PhD from Université Libre de Bruxelles (2009). Research interests include neurocritical care, cortico-cortical connectivity, and optimizing EEG protocols in intensive care settings. His work bridges clinical practice and advanced neurophysiological techniques, aiming to improve patient outcomes in severe neurological emergencies. Key contributions include studies on single-pulse electrical stimulation reducing seizures and the role of sodium DL-3-ß-hydroxybutyrate in neuroprotection post-cardiac arrest. Publications (2023–2025) emphasize epilepsy syndromes, critical care EEG applications, and multicenter studies on treatment adherence and long-term outcomes. His team actively engages in NORSE/FIRES registry analyses to characterize disease progression and communication trends. Grants and funding details are not explicitly listed, but his research aligns with Yale’s focus on translational neurology.
Professor Emanuele (Manuel) Trucco is the NRP Chair of Computational Vision in the Department of Computing, School of Science and Engineering, at the University of Dundee. He holds additional roles as an Honorary Clinical Researcher at NHS Tayside and formerly served as an Adjunct Professor at the Chinese Academy of Sciences from 2018 to 2021. He earned his MSc and PhD in Electronic Engineering from the University of Genoa, Italy, in 1984 and 1990, respectively. His research focuses on medical image and data analysis, particularly in retinal imaging, using machine and deep learning techniques. He is co-director of VAMPIRE, a major international initiative in retinal image analysis, which supports biomarker studies in cardiovascular disease, diabetes, dementia, and neurodegenerative disorders. His recent work includes AI-driven tools for predicting dementia from brain scans and cardiovascular risk from retinal images. The latest publications reflect strong trends in applying deep learning to retinal and brain imaging for early disease detection, with themes centered on AI in healthcare, precision medicine, and non-invasive diagnostics. FRSA (Fellow of the Royal Society of Arts) FIAPR (Fellow of the International Association for Pattern Recognition) Professor Trucco has led and co-led significant research projects funded by EPSRC, NIHR, and EU programs. He has supervised PhD students through industry-sponsored studentships (e.g., OPTOS, NIDEK, Toshiba) and collaborated with institutions such as the Universities of Edinburgh and Liverpool. His research is supported by extensive industrial partnerships including Canon Medical, Epipole plc, and NIDEK. He is a key member of the UK Biobank Eye and Vision Consortium and co-director of the VAMPIRE initiative, a collaborative effort between the Universities of Dundee and Edinburgh focused on retinal image analysis. His work also involves participation in major research networks such as the Academic Health Science Partnership in Tayside.
Dr. Emily Lee serves as an Assistant Professor at Yale School of Medicine in the Department of Obstetrics, Gynecology & Reproductive Sciences, with a clinical focus in Maternal-Fetal Medicine. She completed her Maternal-Fetal Medicine fellowship at Yale in 2023 following her Obstetrics & Gynecology residency at UCLA. Dr. Lee earned her MD from the University of Michigan and completed her undergraduate studies at Yale University with a BA in Economics and Religious Studies. Dr. Lee's research primarily focuses on advancing fetal monitoring techniques, particularly in the areas of obstetric ultrasound and non-invasive fetal electroencephalography. Her work explores innovative approaches to prenatal diagnosis, fetal development assessment, and improving clinical outcomes in complex pregnancies including twin gestations. She has developed simulation-based educational programs for obstetric ultrasound training that enhance clinical skills for medical learners. Her recent publications demonstrate a strong emphasis on improving diagnostic accuracy in fetal cardiac assessment, understanding the implications of maternal obesity on prenatal procedures, and developing novel methods for non-invasive fetal neurological monitoring. Dr. Lee's research bridges clinical practice with technological innovation in maternal-fetal medicine. Among her notable recognitions are the prestigious 2024 Blavatnik Award and the Yale Innovation Summit Blavatnik Accelerator Award in 2023, highlighting her contributions to medical innovation. She has also received the Best Maternal-Fetal Medicine Oral Presentation award from the New England Perinatal Society in 2023, along with earlier recognition for her research at UCLA and international conferences. Dr. Lee actively contributes to medical education through her Point-of-Care Ultrasound Simulation Curriculum and regularly presents on topics including substance use in pregnancy, marijuana usage effects, and advanced fetal monitoring techniques. Her work with the Reproductive Sciences department at Yale focuses on translating research into clinical practice to improve maternal and fetal outcomes.
Daniel B. Vigneron, PhD is a Professor at the University of California, San Francisco (UCSF) Department of Radiology and Biomedical Imaging. He serves as Director of the Hyperpolarized MRI Technology Resource Center (HMTRC), Director of Human Imaging Core Services, Director of Advanced Imaging Technologies SRG, and Operations Director of the Surbeck Laboratory for Advanced Imaging. As a core member of the UCB/UCSF Graduate Group in Bioengineering, Vigneron has established himself as a leader in molecular imaging research with over three decades of experience at UCSF. Vigneron's research focuses on developing advanced functional and metabolic MRI techniques, particularly hyperpolarized carbon-13 technology, for studying prostate cancer, brain tumors, and other diseases. His work enables non-invasive imaging of metabolic processes, allowing clinicians to monitor therapy effectiveness and guide treatments. The HMTRC, which he founded in 2011 with NIH funding and recently secured a 5-year renewal for, has supported 20 external projects domestically and 15 internationally, produced 239 publications, and trained 149 researchers. Vigneron's lab develops novel coil and software techniques for high-field MRI, MR spectroscopy, and diffusion imaging at 3T and 7T for studying brain, prostate cancer, and other organs. His recent publications demonstrate a clear trajectory toward clinical translation of hyperpolarized carbon-13 MRI across multiple organ systems. The research spans abdominal imaging with advanced denoising techniques, cardiac metabolism studies, whole-brain coverage applications, and cerebral perfusion analysis. This work represents a significant shift from basic science toward practical clinical applications in oncology, cardiology, and neurology, with particular emphasis on standardization for multi-center studies. Scientific Awards: 2022 Outstanding Faculty Mentoring Award from UCSF Department of Radiology and Biomedical Imaging Vigneron has mentored 149 trainees throughout his career, with several former students now serving as faculty members including Duan Xu, Peder Larson, and Susan Noworolski. As Principal Investigator overseeing eight grants, he has secured significant NIH funding for the HMTRC and other research initiatives. His administrative leadership extends to co-chairing the department's Safety and Compliance Committee, where he has helped establish robust safety protocols for PET-MR programs. Vigneron's mentoring philosophy emphasizes adapting to individual needs at different career stages, moving from instructor to coach to manager to cheerleader as trainees progress. The Vigneron Lab, located in Byers Hall on the UCSF Mission Bay campus, operates within the Surbeck Laboratory for Advanced Imaging. The lab group develops novel acquisition techniques and hardware for multinuclear MR spectroscopy, with particular focus on hyperpolarized carbon-13 metabolic imaging. The HMTRC serves as a hub for team science, bringing together researchers from diverse disciplines to advance metabolic imaging technology and its clinical applications.
Dr. Michael Stevens is a Senior Lecturer at University of New South Wales (UNSW) Canberra , where he focuses on advanced manufacturing and biomedical device control systems . His work bridges digital manufacturing for SMEs with smart artificial heart technologies , emphasizing industry collaboration and translational research. Specializes in physiological control systems for rotary blood pumps Develops unobtrusive fall detection systems for dementia patients Leads international projects on total artificial heart development Education : B.Eng (Medical - First Class Honours), Queensland University of Technology (2010) PhD in Physiological Control for Biventricular Assist Devices, University of Queensland (2014) Research Trends show consistent focus on: Machine learning for biomedical diagnostics (2018–2025) mmWave radar and thermal sensors in patient monitoring (2021–2024) Computational fluid dynamics in artificial heart modeling (2016–2024) Physiological control algorithms for rotary blood pumps (2011–2025) Scientific Awards : UNSW Scientia Education Award (2021) for contextual teaching Heart Foundation Runner-up for "Smart Artificial Hearts" pitch (2021) ARC PGC Supervisor Award (2017) for mentoring Grants & Supervision : Holds over $6 million in competitive funding including MRFF and ARC grants. Currently supervises 4 PhD students while maintaining industry partnerships with VitalCare and BiVACOR. Labs & Facilities : Works across UNSW Engineering labs and Graduate School of Biomedical Engineering platforms, including mock circulation loops and high-performance computing clusters for CFD simulations.
Raymond T. Ng is a Professor of Computer Science at the University of British Columbia (UBC) and serves as Director of the Data Science Institute . In addition, he is the part-time Chief Informatics Officer at the PROOF Centre of Excellence for the Prevention of Organ Failures located at St Paul’s Hospital. Since 2016 he has held the prestigious Canada Research Chair in Data Science and Analytics. Education B.Sc. (Hons.) Computer Science, University of British Columbia, 1986 M.Math. Computer Science, University of Waterloo, 1988 Ph.D. Computer Science, University of Maryland, College Park, 1992 Research Interests Professor Ng’s research lies at the intersection of data mining , text mining , health informatics , sensor analytics , and databases . Over the past decade he has focused on two major domains: Genomics & Biomarker Discovery: Developing multi-omics biomarker panels for heart, lung and kidney transplant rejection and COPD exacerbations using transcriptomics, proteomics and metabolomics data. Natural Language Processing: Mining and summarizing conversational text such as emails, blogs and meeting transcripts to generate structured metadata and actionable insights. Scientific Awards Canada Research Chair in Data Science and Analytics (2016-2026) Best Paper Award, ACM SIGMOD 2004 Best Paper Award, ACM SIGKDD 2001 Selected among Best Papers of VLDB ’99 & ’98 Governor General’s Gold Medal, UBC (1986) Research Funding & Leadership Since joining UBC in 1992, Professor Ng has continuously secured major peer-reviewed funding from NSERC, CIHR, Genome Canada, CFI, MITACS and industry partners (Google, IBM, SAP). He leads or co-leads several large-scale initiatives: HEARTBiT multi-marker blood test for cardiac transplant rejection (CIHR 2018-2021) MERIDIAN ocean acoustic data infrastructure (CFI 2018-2021) Pan-Canadian Early Detection of Lung Cancer (Terry Fox 2018-2021) Business Intelligence Network (NSERC 2009-2014) Multiple Genome Canada programs on biomarker translation (2004-2018) Laboratories & Teams Professor Ng directs the Data Science Institute and works closely with the Natural Language Processing Research Group . At the PROOF Centre he heads a multidisciplinary team of statisticians, computer scientists and clinicians advancing computational biomarker pipelines from discovery to clinical implementation.
Adrian Chan is a Professor at Carleton University's Department of Systems and Computer Engineering, Faculty of Engineering and Design. He holds the title of Director of the Research and Education in Accessibility, Design, and Innovation (READi) program. His expertise spans biomedical engineering, signal processing, and accessibility technologies. Education: Ph.D. in Electrical Engineering (University of New Brunswick), M.A.Sc. in Electrical Engineering (University of Toronto), B.A.Sc. in Computer Engineering (University of Waterloo). Research focuses on non-invasive sensors, biomedical signal/image processing, machine learning, and accessibility solutions. Notable projects include the Abilities Living Laboratory and collaborations with healthcare institutions like The Ottawa Hospital. His work addresses challenges in neonatal transport safety, placental imaging for maternal health, and wearable medical devices. Publications highlight advancements in AI-driven ECG analysis, histopathology segmentation, and clinical monitoring systems. Over 150 students have been mentored, with many securing prestigious awards. Awards include the 2024 CMBES Fellowship, 2023 Carleton Research Achievement Award, and 2012 3M Teaching Fellowship. Grants include NSERC CREATE programs and CFI funding for the Abilities Living Laboratory. Leadership roles include interim Assistant Vice-President (Academic), Associate Dean (Graduate Programs), and Shad Valley Program Director. Active in community initiatives like the READi training program and accessibility advocacy.
Robert T. Tranquillo serves as a Distinguished McKnight University Professor in the Department of Biomedical Engineering at the University of Minnesota's College of Science and Engineering. His research focuses on developing biologically-engineered vascular grafts, heart valves, and vein valves using tissue engineering approaches. Notably, his lab has demonstrated that their engineered material, produced by skin cells (fibroblasts), has the capacity to grow, which may transform the treatment of pediatric congenital heart defects. Tranquillo's research interests center on cardiovascular tissue engineering, particularly the development of "off-the-shelf" vascular grafts and heart valves. His lab fabricates tissue-equivalents by entrapping fibroblasts in fibrin gel and constraining cell-mediated gel compaction to create aligned fibrin structures. Using bioreactors, they stimulate cells to replace aligned fibrin with collagenous matrix, creating tubes suitable for surgical implantation. Upon decellularization, these become non-immunogenic replacements that support host recellularization and growth. His current work focuses on transcatheter heart valves and vein valves, combining engineered matrix tubes with stent technology, and conferring hemocompatibility using stem cell and small molecule strategies. A key aspect of his research investigates contact guidance—the ability of cells to sense and align with fibers—which is crucial for creating tissues with prescribed alignment. His publication record shows consistent output in top journals including Nature Communications, Science Translational Medicine, and PNAS, with recent work focusing on contact guidance mechanisms, pediatric valve conduits, and transcatheter valve development. His research demonstrates a clear trajectory from fundamental biomechanics to translational applications in cardiovascular medicine. Distinguished McKnight University Professor (prestigious University of Minnesota honor) Tranquillo has mentored over 40 PhD students and postdocs who have gone on to prominent positions in academia (professors at UCLA, Rutgers, Penn State), industry (Medtronic, Abbott, Boston Scientific), and government (NSF, NRO). His lab has received substantial research funding supporting their work on tissue-engineered cardiovascular replacements. The Tranquillo Research Group maintains an active website detailing their current projects and methodologies. The Tranquillo Research Group operates within the Department of Biomedical Engineering at the University of Minnesota, with laboratory facilities focused on tissue engineering, biomechanics, and cardiovascular device development. Their work bridges fundamental cell-matrix interactions with translational applications for cardiovascular disease treatment.
Maarten De Vos is a Professor at the Department of Electrical Engineering (ESAT) , KU Leuven , with dual appointments in the Faculty of Medicine and Faculty of Engineering Science . He leads interdisciplinary research at the intersection of artificial intelligence and biomedical signal processing.
Joo Heung Yoon, MD is an Assistant Professor of Medicine in the Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine at the University of Pittsburgh School of Medicine. His research develops machine learning models for predicting hemodynamic instability in critical care settings, with applications extending to space medicine environments. His educational background includes: MD from Catholic University of Korea, Seoul, South Korea (2002) Internal Medicine Internship at Maimonides Medical Center - SUNY Downstate (2007) Internal Medicine Residency at New York Medical College (2009) Research Fellowship at Massachusetts General Hospital / Harvard Medical School (2011) Research Fellowship at Beth Israel Deaconess Medical Center / Harvard Medical School (2014) Fellowship in Pulmonary and Critical Care Medicine at University of Pittsburgh School of Medicine (2017) Dr. Yoon specializes in identifying hidden pathologic patterns through machine learning, developing prediction models for shock, hemorrhage, and tachycardia using large-scale clinical data. His work bridges critical care medicine with AI, focusing on real-world ICU implementation through alert systems and user interfaces. He actively explores microgravity applications, aiming to create feasible prediction algorithms for resource-constrained space missions where timely high-stake decisions are critical. His publication trend (2018-2020) reveals consistent advancement in hemodynamic prediction models, transitioning from theoretical frameworks to practical implementation strategies. These works integrate supervised ML and deep neural networks to address circulatory shock, hemorrhage identification, and instability surrogates, demonstrating strong interdisciplinary collaboration between clinical medicine and engineering. Notable awards include: SCCM Gold Snapshot Award (2019) ATS Abstract Award (2018) Excellence in Clinical Service Award (2010) Partners in Excellence Award (2009) Richard D. Levere Teaching Award (2008) As Principal Investigator for NIH K23 grant GM138984 (2020-2025), Dr. Yoon leads research on machine learning-driven shock prediction models. He mentors medical students and house staff daily in the ICU, specializing in cardiopulmonary physiology teaching. His grant portfolio focuses on therapeutic strategies for circulatory shock in critically-ill patients, with strong industry-academic partnerships. Based at UPMC Montefiore, Dr. Yoon collaborates with Carnegie Mellon University's Machine Learning School and Pitt Engineering to develop clinical decision support systems. His team is designing graphic user interfaces for spaceflight applications where resource limitations demand highly efficient predictive analytics for hemodynamic crises.
